查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
到2028年的生物程序技術市場規模和預測 - COVID-19的影響以及按類型、模式和終端用戶的全球分析
市場調查報告書
商品編碼
1296742

到2028年的生物程序技術市場規模和預測 - COVID-19的影響以及按類型、模式和終端用戶的全球分析

Bioprocess Technology Market Size and Forecast to 2028 - Global Analysis by Type, Modality, and End User
出版日期: | 出版商: The Insight Partners | 英文 194 Pages | 訂單完成後即時交付

價格

生物程序技術市場規模預計將從2022年的308.9億美元成長到2028年的770.9億美元。據估計，從2022年到2028年，該市場的年複合成長率為16.8%。

全球生物程序技術市場的成長主要是由引進新藥物化合物的研發支出的成長和慢性病患病率的增加所驅動。然而，嚴格的監管政策阻礙了市場的成長。

生物程序技術採用微觀生命，作為生物工廠，造福人類。在生物程序技術中，微生物在受控的環境中生長，包括用糖和棕櫚油廠廢料等基質的飼料。這些成分轉化為商業上有用的生物成分，如蛋白質、平台化學品和脂類。此外，執行良好的生物程序技術轉讓在確保順利的知識轉讓和最佳的程序可重複性方面發揮關鍵作用。

亞太地區的生物程序技術市場佔有率的年複合成長率最快。在亞太地區，中國在2022-2028年期間佔有相當大的生物程序技術市場的佔有率。此外，在2022-2028年的預測期內，印度的生物程序技術市場將保持相當大的年複合成長率，即21.3%。印度是著名的生物程序外包目的地，是活性藥物成分（API）和原料的主要供應商。另外，印度的生物程序能力高度依賴於其合格的勞動力和成本效率，這為市場創造了成長機會。另外，小分子製造是該國製藥和生物技術公司的優勢。小分子製藥產品被認為是學名藥，在美國、歐洲等國際市場上得到廣泛認可。

此外，印度包括參與開發細胞和基因治療的生物學名藥的早期企業家，以及各種頂級公司宣佈在該國推出創新產品。 2022年5月，科德寶醫療公司宣佈在印度推出一種新產品｢HeliFlex｣。該產品是一種高純度熱塑性彈性體TPE管，設計用於生物製藥流體傳輸應用。這種TPE管是製藥生物加工應用的理想選擇，因為它可以焊接到現有的管線上，並進行熱封，從而在生物製藥過程中實現快速、安全、便捷的流體輸送。

北美主導了生物程序技術市場，佔最大佔有率。該地區生物程序技術市場的成長歸因於大型企業推出創新產品（特別是與生物程序技術有關的產品），該地區的產品引進不斷增加，以及生物程序技術的技術進步。在北美，美國記錄了生物程序技術的最大佔有率。根據美國食品和藥物管理局（FDA）的報告，美國有3000多萬人患有約7000種罕見的疾病，這些疾病威脅著人們的生命，而且治療方法很少。由於缺乏對罕見疾病歷史的了解，以及難以進行臨床試驗，治療罕見疾病的藥物、生物和設備開發具有挑戰性。因此，生物程序技術的發展，如基因和細胞療法（CGTs）和特殊藥品，代表了罕見疾病治療的根本性轉變。例如，與治療罕見疾病的配方藥物相比，CGTs已顯示出明顯的健康效益。在美國，有900多個針對基因療法產品的新藥研究（IND）申請進行中。同時，每年有10-20種基因療法被美國食品和藥物管理局批准。同樣，在2022年8月，FDA批准了藍鳥生物的"Zynteglo（betibeglogene autotemcel）"。這是美國最昂貴的單一應用藥物批准，旨在治療一種罕見的神經系統疾病- 腦腎上腺白質營養不良症（CALD）。

自動即時流式細胞儀（ART FCM）的出現

在過去的十年裡，流式細胞儀（FCM）及其技術可能性有了很大的發展，成為生物反應器中不同類型細胞的單細胞特性和群體分佈的分析工具。在這一過程中，一些自動即時流式細胞儀（ART FCM）解決方案開發出來，用於監測生物反應器的過程，而不需要操作者在長時間內以可變採樣頻率進行干擾。

ART FCM可以在不遺漏生物過程中任何重要事件的情況下進行長期測量，並發現可能是未知的、應進行更詳細研究的時間現象。另外，更頻繁的測量可以按照用戶定義的頻率進行，與人員的可用性無關。當與僅在單細胞水準上部分可用的組學等方法相比，透過ART-FCM可以很容易地建立多參數測量，而不需要延長勞動和時間的努力。

與傳統的FCM研究相比，微流控設備作為晶片上的ART FCM，未來潛力巨大。在這種情況下，並行化可能變得更加重要，因為來自不同生物反應器或生物反應器設置內不同位置的樣品可以同時進行分析。許多方面也可適用於其他實驗裝置，其中快速和可重複的即時監測螢光過程參數也很有意義。總之，ART-FCM很可能會在未來幾年內呈指數級發展。

COVID-19大流行對生物程序技術市場產生了積極影響。截至5月中旬，超過215種用於治療COVID-19的新型和重新利用的療法進行中，來自流行病預防創新聯盟和Melinda and Gates基金會等組織的投資不斷增加。此外，生物製藥公司還為商業生產進行了額外的投資。在這場大流行中，投資增加了對生物加工技術的採用，大規模地提高了效率和生產力。此外，在區域市場開設了良好的基礎設施，最終將加速該地區的供應鍊和生物加工設施。

基於類型的洞察力

根據類型，生物程序技術市場分類為細胞培養基生物程序、色譜生物程序、消耗品和配件及其他。 2022年，細胞培養基生物程序部分在生物程序技術中佔有最大的市場佔有率，而色譜生物程序預計在預測期內（2023-2028年）會有最高的年複合成長率。

基於模式的洞察力

基於模式，全球生物程序技術市場分為單一用途和多種用途。 2022年，單一用途部分占生物程序技術的較大市場佔有率。在預測期內，多種用途部分預計將以更高的年複合成長率成長。

基於終端用戶的洞察力

在終端用戶方面，生物程序技術市場分為學術和醫療機構、生物製藥公司、研究實驗室和其他。 2022年，生物製藥公司部分佔據了最大的市場佔有率，而學術和醫療機構預計在預測期內將有更高的年複合成長率。

生物程序技術市場：競爭格局和主要發展情況

Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc, Corning Inc, STAMM Biotech, Lonza Group AG, Eppendorf SE, Repligen Corp, Danaher Corp, BioPharma Dynamics是在全球生物程序技術市場運作的主要公司之一。領先的企業致力於擴大和多樣化他們的市場存在和客戶，從而挖掘出普遍的商業機會。

2022年6月，Merck公司與Agilent科技公司達成合作，推進過程分析技術（PAT）。全球監管機構大力鼓勵的PAT，是即時發布和生物程序4.0的關鍵推動因素。

2020年3月，Sartorius推出了BIOSTAT STR第三代一次性生物反應器和BIOBRAIN自動化平台，推出了將改變生物製藥程序開發和製造領域的創新。 Biostat STR簡化了生物製品的生產。

目錄

第一章：簡介

  • 本研究的範圍
  • Insight Partners的研究報告指南
  • 市場細分
    • 全球生物程序技術市場- 按類型分類
    • 全球生物程序技術市場- 按模式分類
    • 全球生物程序技術市場- 按終端用戶分類
    • 全球生物程序技術市場- 按地域分類

第二章：生物程序技術市場- 主要結論

第三章：研究方法

  • 涵蓋範圍
  • 二級研究
  • 初級研究

第四章：生物程序技術市場- 市場格局

  • 市場概況
  • PEST分析
    • 北美洲PEST分析
    • 歐洲PEST分析
    • 亞太地區PEST分析
    • 南美洲和中美洲PEST分析
    • 中東和非洲PEST分析
  • 專家的意見

第五章：生物程序技術市場- 主要市場動態

  • 市場驅動力
    • 引進新藥物化合物的研發支出不斷增加
    • 慢性病的發病率不斷上升
  • 市場限制因素
    • 嚴格的監管政策
  • 市場機會
    • 引進先進的生物程序技術
  • 未來趨勢
    • 引進自動即時流式細胞儀(ART FCM)
  • 影響分析

第六章：生物程序技術市場- 全球分析

  • 全球生物程序技術市場收入預測和分析
  • 全球生物程序技術市場，按地域分類- 預測和分析
  • 主要參與者的市場定位

第七章：全球生物程序技術市場- 2028年的收入和預測- 按類型分類

  • 概況
  • 2022年和2028年按類型分類的生物程序技術市場收入佔有率(%)
  • 細胞培養基生物程序
  • 色譜生物程序
  • 耗材和配件
  • 其他類型

第八章：2028年全球生物程序技術市場分析和預測- 按模式分類

  • 概況
  • 2022年和2028年全球生物程序技術市場，按模式分類（%）
  • 單一用途
  • 多種用途

第九章：全球生物程序技術市場- 2028年的收入和預測- 按終端用戶分類

  • 概況
  • 2022年和2028年按終端用戶分類的生物程序技術市場收入佔有率(%)
  • 學術和醫療機構
  • 生物製藥公司
  • 研究實驗室
  • 其他機構

第十章：生物程序技術市場- 收入和對2028年的預測- 地域分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 亞太其他地區
  • 中東和非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第十一章：COVID-19大流行對生物程序技術市場的影響

  • 北美洲
  • 歐洲
  • 亞太地區
  • 中東和非洲
  • 南美洲和中美洲

第十二章：生物程序技術市場- 行業格局

  • 概況
  • 生物程序技術市場的成長戰略
  • 有機成長戰略
    • 概況
  • 無機成長戰略
    • 綜述

第十三章：公司簡介

  • Merck KGaA
  • Sartorius AG
  • Thermo Fisher Scientific Inc
  • Corning Inc
  • STAMM Biotech
  • Lonza Group AG
  • Eppendorf SE
  • Repligen Corp
  • Danaher Corp
  • BioPharma Dynamics Ltd

第十四章：附錄

  • 關於Insight Partners
  • 術語表
Product Code: TIPHE100001373

The bioprocess technology market size is expected to grow from US$ 30.89 billion in 2022 to US$ 77.09 billion by 2028. The market is estimated to register a CAGR of 16.8% from 2022 to 2028.

The growth of the global bioprocess technology market growth is majorly driven by growing R&D spendings to introduce new drug compounds and increasing prevalence of chronic diseases. However, stringent regulatory policies hamper the market growth.

Bioprocess technology employs microscopic life, acting as a biological factory to benefit mankind. In bioprocess technology, microorganisms are grown in a controlled environment comprising feed with substrates such as sugar and palm oil mill waste. These ingredients transform to form commercially useful biological components such as proteins, platform chemicals, and lipids. Also, a well-executed bioprocess technology transfer plays a critical role in ensuring smooth knowledge transfer and optimal process reproducibility.

Asia Pacific region registers fastest growing CAGR for bioprocess technology market share. Among Asia Pacific region, China holds considerable share for bioprocess technology market during 2022-2028. Additionally, India will hold considerable CAGR of 21.3% for bioprocess technology market during the forecast period of 2022-2028. India is a well-known destination for bioprocess outsourcing, standing as a major supplier of active pharmaceutical ingredients (API) and raw materials. Also, India's bioprocessing capability is highly dependent on its qualified workforce and cost efficiencies, which creates growth opportunities for the market. Also, small molecule manufacturing is the strength of the pharma and biotechnology companies in the country. Small molecule pharmaceutical products are considered generics and well recognized across the international markets of the US, Europe, etc.

In addition, India comprises early-stage entrepreneurs involved in developing biosimilars in cell and gene therapy, and various top companies announced innovative product launches in the country. In May 2022, Freudenberg Medical announced the launch of a new product, "HeliFlex," in India. The product is a high-purity thermoplastic elastomer TPE tubing designed for utility in biopharmaceutical fluid transfer applications. The TPE tubing is ideal for pharmaceutical bioprocessing applications as it can be welded to existing tubing lines and heat-sealed, allowing fast, safe, and easy fluid transport in the biopharma process.

North America dominated the bioprocess technology market accounting maximum share. The bioprocess technology market growth in this region is attributed due to the presence of large players launching innovative products (particularly related to bioprocess technology), growing product introduction in the region, and technological advancements in bioprocess technology. In North America, the US records maximum share for the bioprocess technology. According to the Food and Drug Administration (FDA) report, over 30 million people in the US suffer from ~7,000 rare diseases, accounting for life-threatening conditions with low treatment options. Drug, biological, and device development in the treatment of rare diseases is challenging due to a lack of understanding of the history of rare diseases and difficulty in conducting clinical trials. Therefore, the growth of bioprocess technologies such as gene and cell therapies (CGTs) and specialty pharmaceuticals represent a radical shift in the treatment of rare diseases. For example, CGTs have revealed significant health benefits than formulated drugs for treating rare diseases. In the US, more than 900 investigational new drug (IND) applications targeting gene therapy products are underway. Also, 10-20 gene therapies are approved annually by the FDA. Likewise, in August 2022, the FDA approved Bluebird Bio's "Zynteglo (betibeglogene autotemcel)." It was the most expensive single-application drug approval in the US intended for the treatment of a rare neurological disorder-cerebral adrenoleukodystrophy (CALD).

Emergence of Automated Real?Time Flow Cytometry (ART?FCM)

Flow cytometry (FCM) and its technological possibilities have greatly advanced in the past decade as an analysis tool for single-cell properties and population distributions of different cell types in bioreactors. Along the way, a few automated real?time flow cytometry (ART?FCM) solutions were developed for monitoring bioreactor processes without operator interference over extended periods with a variable sampling frequency.

ART?FCM enables long?term measurements without missing any important events in bioprocesses and uncovers temporal phenomena that are likely unknown and should be investigated in greater detail. Also, more frequent measurements can be performed at a user-defined frequency, independent of the availability of personnel. When compared with methods such as omics that are only partially available on a single-cell level, multi-parameter measurements can be easily established without the extended effort of labor and time via ART-FCM.

Compared with conventional FCM studies, microfluidic devices great future potential as ART?FCM on a chip. In this context, parallelization might become more relevant, as samples from different bioreactors or different locations inside a bioreactor setup could be analyzed simultaneously. Many aspects might also be adapted to other experimental setups where fast and reproducible real?time monitoring of fluorescent process parameters is also of interest. In conclusion, ART?FCM will most probably advance exponentially in the upcoming years.

The COVID-19 pandemic had a positive impact on the bioprocess technology market. By mid-May, more than 215 novel and repurposed therapies were in the pipeline for the treatment of COVID-19, with rising investment from organizations such as the Coalition for Epidemic Preparedness Innovations and Melinda and Gates Foundation. Also, additional investments were made by the biopharmaceutical companies for commercial manufacturing. Amid the pandemic, the investment increased the adoption of bioprocessing technologies, enhancing efficiency and productivity at a large scale. Moreover, well-infrastructure facilities in regional markets were opened that will ultimately accelerate towards supply chain and bioprocessing facilities in the region.

Type-Based Insights

Based on type, the bioprocess technology market is segmented into cell culture media bioprocess, chromatography bioprocess, consumables & accessories, and others. The cell culture media bioprocess segment held a largest market share of bioprocess technology in 2022 whereas chromatography bioprocess is anticipated to register a highest CAGR during the forecast period (2023-2028).

Modality-Based Insights

Based on modality, the global bioprocess technology market is bifurcated into single use and multiple use. The single use segment accounted a larger market share for bioprocess technology in 2022. The multiple use segment is expected to grow at a higher CAGR during the forecast period.

End User-Based Insights

In terms of end user, the bioprocess technology market is categorized into academic & medical institutions, biopharmaceutical companies, research laboratories, and others. The biopharmaceutical companies segment held a largest market share in 2022, whereas academic & medical institutions is expected to register a higher CAGR during the forecast period.

Bioprocess Technology Market: Competitive Landscape and Key Developments

Merck KGaA, Sartorius AG, Thermo Fisher Scientific Inc, Corning Inc, STAMM Biotech, Lonza Group AG, Eppendorf SE, Repligen Corp, Danaher Corp, BioPharma Dynamics are among the key companies operating in the global bioprocess technology market. Leading players focus on expanding and diversifying their market presence and clientele, thereby tapping prevailing business opportunities.

In June 2022, Merck has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0.

In March 2020, Sartorius launched BIOSTAT STR Generation 3 single-use bioreactor and BIOBRAIN automation platform to introduce innovations that will change the field of biopharmaceutical process development and manufacturing. Biostat STR simplifies biologics production.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the global bioprocess technology market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global bioprocess technology market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Bioprocess Technology Market - by Type
    • 1.3.2 Global Bioprocess Technology Market - by Modality
    • 1.3.3 Global Bioprocess Technology Market - by End User
    • 1.3.4 Global Bioprocess Technology Market - by Geography

2. Bioprocess Technology Market - Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Bioprocess Technology Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis
  • 4.3 Expert's Opinion

5. Bioprocess Technology Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Growing R&D Spendings to Introduce New Drug Compounds
    • 5.1.2 Increasing Prevalence of Chronic Diseases
  • 5.2 Market Restraints
    • 5.2.1 Stringent Regulatory Policies
  • 5.3 Market Opportunities
    • 5.3.1 Introducing Advanced Bioprocess Technologies
  • 5.4 Future Trends
    • 5.4.1 Introduction of Automated Real?Time Flow Cytometry (ART?FCM)
  • 5.5 Impact Analysis

6. Bioprocess Technology Market - Global Analysis

  • 6.1 Global Bioprocess Technology Market Revenue Forecast and Analysis
  • 6.2 Global Bioprocess Technology Market, by Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Global Bioprocess Technology Market - Revenue and Forecast to 2028 - by Type

  • 7.1 Overview
  • 7.2 Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
  • 7.3 Cell Culture Media Bioprocess
    • 7.3.1 Overview
    • 7.3.2 Cell Culture Media Bioprocess: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Chromatographic Bioprocess
    • 7.4.1 Overview
    • 7.4.2 Chromatographic Bioprocess: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.5 Consumables & Accessories
    • 7.5.1 Overview
    • 7.5.2 Consumables & Accessories: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

8. Global Bioprocess Technology Market Analysis and Forecasts to 2028 - by Modality

  • 8.1 Overview
  • 8.2 Global Bioprocess Technology Market, by Modality 2022 & 2028 (%)
  • 8.3 Single Use
    • 8.3.1 Overview
    • 8.3.2 Single Use: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Multiple Use
    • 8.4.1 Overview
    • 8.4.2 Multiple Use: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

9. Global Bioprocess Technology Market - Revenue and Forecast to 2028 - by End User

  • 9.1 Overview
  • 9.2 Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
  • 9.3 Academic & Medical Institutions
    • 9.3.1 Overview
    • 9.3.2 Academic & Medical Institutions: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Biopharmaceutical Companies
    • 9.4.1 Overview
    • 9.4.2 Biopharmaceutical Companies: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Research Laboratories
    • 9.5.1 Overview
    • 9.5.2 Research Laboratories: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)

10. Bioprocess Technology Market - Revenue and Forecast to 2028 - Geographic Analysis

  • 10.1 North America: Bioprocess Technology Market
    • 10.1.1 Overview
    • 10.1.2 North America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.1.3 North America: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    • 10.1.4 North America: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    • 10.1.5 North America: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.5.1 US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.1.1 Overview
        • 10.1.5.1.2 US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.1.3 US: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.5.1.4 US: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.5.1.5 US: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.5.2 Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.2.1 Overview
        • 10.1.5.2.2 Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.2.3 Canada: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.5.2.4 Canada: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.5.2.5 Canada: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.1.5.3 Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.3.1 Overview
        • 10.1.5.3.2 Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.1.5.3.3 Mexico: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.1.5.3.4 Mexico: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.1.5.3.5 Mexico: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  • 10.2 Europe: Bioprocess Technology Market
    • 10.2.1 Overview
    • 10.2.2 Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.2.3 Europe: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    • 10.2.4 Europe: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    • 10.2.5 Europe: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.2.6 Europe: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
      • 10.2.6.1 Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.1 Overview
        • 10.2.6.1.2 Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.1.3 Germany: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.1.4 Germany: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.2.6.1.5 Germany: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.2.6.2 UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.1 Overview
        • 10.2.6.2.2 UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.2.3 UK: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.2.4 UK: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.2.6.2.5 UK: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.2.6.3 France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.1 Overview
        • 10.2.6.3.2 France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.3.3 France: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.3.4 France: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.2.6.3.5 France: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.2.6.4 Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.1 Overview
        • 10.2.6.4.2 Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.4.3 Italy: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.4.4 Italy: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.2.6.4.5 Italy: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.2.6.5 Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.1 Overview
        • 10.2.6.5.2 Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.5.3 Spain: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.5.4 Spain: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.2.6.5.5 Spain: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.2.6.6 Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.1 Overview
        • 10.2.6.6.2 Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.2.6.6.3 Rest of Europe: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.2.6.6.4 Rest of Europe: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.2.6.6.5 Rest of Europe: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  • 10.3 Asia Pacific: Bioprocess Technology Market
    • 10.3.1 Overview
    • 10.3.2 Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.3.3 Asia Pacific: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    • 10.3.4 Asia Pacific: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    • 10.3.5 Asia Pacific: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.3.6 Asia Pacific: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
      • 10.3.6.1 China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.1 Overview
        • 10.3.6.1.2 China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.1.3 China: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.1.4 China: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.3.6.1.5 China Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.3.6.2 Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.1 Overview
        • 10.3.6.2.2 Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.2.3 Japan: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.2.4 Japan: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.3.6.2.5 Japan: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.3.6.3 India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.1 Overview
        • 10.3.6.3.2 India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.3.3 India: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.3.4 India: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.3.6.3.5 India: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.3.6.4 South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.1 Overview
        • 10.3.6.4.2 South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.4.3 South Korea: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.4.4 South Korea: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.3.6.4.5 South Korea: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.3.6.5 Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.1 Overview
        • 10.3.6.5.2 Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.5.3 Australia: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.5.4 Australia: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.3.6.5.5 Australia: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.3.6.6 Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.1 Overview
        • 10.3.6.6.2 Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.3.6.6.3 Rest of Asia Pacific: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.3.6.6.4 Rest of Asia Pacific: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.3.6.6.5 Rest of Asia Pacific: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  • 10.4 Middle East & Africa Bioprocess Technology Market
    • 10.4.1 Overview
    • 10.4.2 Middle East & Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.4.3 Middle East & Africa: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    • 10.4.4 Middle East & Africa: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    • 10.4.5 Middle East & Africa Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.4.6 Middle East & Africa: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
      • 10.4.6.1 UAE: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.1 Overview
        • 10.4.6.1.2 UAE: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.1.3 UAE: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.4.6.1.4 UAE: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.4.6.1.5 UAE Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.4.6.2 Saudi Arabia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.1 Overview
        • 10.4.6.2.2 Saudi Arabia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.2.3 Saudi Arabia: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.4.6.2.4 Saudi Arabia: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.4.6.2.5 Saudi Arabia Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.4.6.3 South Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.1 Overview
        • 10.4.6.3.2 South Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.3.3 South Africa: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.4.6.3.4 South Africa: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.4.6.3.5 South Africa Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.4.6.4 Rest of Middle East & Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.4.1 Overview
        • 10.4.6.4.2 Rest of Middle East & Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.4.6.4.3 Rest of Middle East & Africa: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.4.6.4.4 Rest of Middle East & Africa: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.4.6.4.5 Rest of Middle East & Africa Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
  • 10.5 South & Central America Bioprocess Technology Market
    • 10.5.1 Overview
    • 10.5.2 South & Central America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
    • 10.5.3 South & Central America: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
    • 10.5.4 South & Central America: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
    • 10.5.5 South & Central America: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
    • 10.5.6 South & Central America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
      • 10.5.6.1 Brazil: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.1 Overview
        • 10.5.6.1.2 Brazil: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.1.3 Brazil: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.5.6.1.4 Brazil: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.5.6.1.5 Brazil: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.5.6.2 Argentina: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.1 Overview
        • 10.5.6.2.2 Argentina: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.2.3 Argentina: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.5.6.2.4 Argentina: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.5.6.2.5 Argentina: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)
      • 10.5.6.3 Rest of South & Central America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.1 Overview
        • 10.5.6.3.2 Rest of South & Central America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
        • 10.5.6.3.3 Rest of South & Central America: Bioprocess Technology Market, by Type, 2019-2028 (US$ Million)
        • 10.5.6.3.4 Rest of South & Central America: Bioprocess Technology Market, by Modality, 2019-2028 (US$ Million)
        • 10.5.6.3.5 Rest of South & Central America: Bioprocess Technology Market, by End User, 2019-2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Bioprocess Technology Market

  • 11.1 North America: Impact Assessment of COVID-19 Pandemic
  • 11.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
  • 11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
  • 11.5 South & Central America: Impact Assessment of COVID-19 Pandemic

12. Bioprocess Technology Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Bioprocess Technology Market
  • 12.3 Organic Growth Strategies
    • 12.3.1 Overview
  • 12.4 Inorganic Growth Strategies
    • 12.4.1 Overview

13. Company Profiles

  • 13.1 Merck KGaA
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Sartorius AG
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Thermo Fisher Scientific Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Corning Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 STAMM Biotech
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 Lonza Group AG
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Eppendorf SE
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Repligen Corp
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Danaher Corp
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 BioPharma Dynamics Ltd
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms

List Of Tables

  • Table 1. R&D Investments by Major Pharmaceutical Companies
  • Table 2. North America Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 3. North America Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 4. North America Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 5. US Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 6. US Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 7. US Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Canada Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Canada Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Canada Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Mexico Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Mexico Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Mexico Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Europe Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Europe Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Europe Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Germany Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Germany Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Germany Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 20. UK Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 21. UK Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 22. UK Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 23. France Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 24. France Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 25. France Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 26. Italy Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 27. Italy Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 28. Italy Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 29. Spain Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 30. Spain Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 31. Spain Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 32. Rest of Europe Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 33. Rest of Europe Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 34. Rest of Europe Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 35. Asia Pacific Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 36. Asia Pacific Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 37. Asia Pacific Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 38. China Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 39. China Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 40. China Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 41. Japan Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 42. Japan Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 43. Japan Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 44. India Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 45. India Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 46. India Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 47. South Korea Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 48. South Korea Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 49. South Korea Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 50. Australia Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 51. Australia Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 52. Australia Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 53. Rest of Asia Pacific Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 54. Rest of Asia Pacific Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 55. Rest of Asia Pacific Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 56. Middle East & Africa Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 57. Middle East & Africa Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 58. Middle East & Africa Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 59. UAE Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 60. UAE Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 61. UAE Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 62. Saudi Arabia Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 63. Saudi Arabia Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 64. Saudi Arabia Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 65. South Africa Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 66. South Africa Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 67. South Africa Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 68. Rest of Middle East & Africa Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 69. Rest of Middle East & Africa Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 70. Rest of Middle East & Africa Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 71. South & Central America Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 72. South & Central America Bioprocess Technology Market, by Modality - Revenue and Forecast to 2028 (US$ Million)
  • Table 73. South & Central America Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 74. Brazil Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 75. Brazil Bioprocess Technology Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 76. Brazil Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 77. Argentina Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 78. Argentina Bioprocess Technology Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 79. Argentina Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 80. Rest of South & Central America Bioprocess Technology Market, by Type - Revenue and Forecast to 2028 (US$ Million)
  • Table 81. Rest of South & Central America Bioprocess Technology Market, by Modality- Revenue and Forecast to 2028 (US$ Million)
  • Table 82. Rest of South & Central America Bioprocess Technology Market, by End User - Revenue and Forecast to 2028 (US$ Million)
  • Table 83. Recent Organic Growth Strategies in Bioprocess Technology Market
  • Table 84. Recent Inorganic Growth Strategies in the Bioprocess Technology Market
  • Table 85. Glossary of Terms

List Of Figures

  • Figure 1. Bioprocess Technology Market Segmentation
  • Figure 2. Bioprocess Technology Market, by Geography
  • Figure 3. Global Bioprocess Technology Market Overview
  • Figure 4. Consumables and Accessories Segment Held Largest Share of Type Segment in Bioprocess Technology Market
  • Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
  • Figure 6. Bioprocess Technology Market, by Geography (US$ Million)
  • Figure 7. Global Bioprocess Technology Market - Leading Country Markets (US$ Million)
  • Figure 8. Global Bioprocess Technology Market - Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. South & Central America: PEST Analysis
  • Figure 13. Middle East & Africa: PEST Analysis
  • Figure 14. Experts' Opinion
  • Figure 15. Global Bioprocess Technology Market - Revenue Forecast and Analysis - 2020-2028
  • Figure 16. Global Bioprocess Technology Market, by Geography - Forecast and Analysis (2022-2028)
  • Figure 17. Market Positioning of Key Players in Bioprocess Technology Market
  • Figure 18. Bioprocess Technology Market Revenue Share, by Type 2022 & 2028 (%)
  • Figure 19. Cell Culture Media Bioprocess: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 20. Chromatographic Bioprocess: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Consumables & Accessories: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Others: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 23. Global Bioprocess Technology Market, by Modality 2022 & 2028 (%)
  • Figure 24. Single Use: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Multiple Use: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Bioprocess Technology Market Revenue Share, by End User 2022 & 2028 (%)
  • Figure 27. Academic & Medical Institutions: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Biopharmaceutical Companies: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 29. Research Laboratories: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Others: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. North America: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 32. North America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. North America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
  • Figure 34. US: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Canada: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 36. Mexico: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Europe: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 38. Europe Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Europe: Bioprocess Technology Market, by Country, 2022& 2028 (%)
  • Figure 40. Germany: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 41. UK: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 42. France: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 43. Italy: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 44. Spain: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 45. Rest of Europe: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 46. Asia Pacific: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 47. Asia Pacific Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. China: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 49. Japan: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. India: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. South Korea: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. Australia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Rest of Asia Pacific: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Middle East & Africa: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 55. Middle East & Africa Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 56. UAE: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 57. Saudi Arabia: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 58. South Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 59. Rest of Middle East & Africa: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 60. South & Central America: Bioprocess Technology Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 61. South & Central America Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 62. South & Central America: Bioprocess Technology Market, by Country, 2022 & 2028 (%)
  • Figure 63. Brazil: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 64. Argentina: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 65. Rest of South & Central America: Bioprocess Technology Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 66. Impact of COVID-19 Pandemic on North American Country Markets
  • Figure 67. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 68. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 69. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
  • Figure 70. Impact of COVID-19 Pandemic on South & Central American Country Markets
  • Figure 71. Growth Strategies in Bioprocess Technology Market